Clinical Trial Detail

NCT ID NCT02952534
Title A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON2)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Clovis Oncology, Inc.
Indications

prostate adenocarcinoma

prostate carcinoma

Therapies

Rucaparib

Age Groups: senior adult

Additional content available in CKB BOOST